POPULATION PK AND EXPOSURE-RESPONSE ANALYSES OF APREMILAST IN SUBJECTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kassir, N. [1 ]
Savant, I. [2 ]
Mouksassi, M. S. [1 ]
Marier, J. F. [1 ]
Zhu, W. [2 ]
Lau, H. [2 ]
机构：
[1] Pharsight Corp, Montreal, PQ, Canada
[2] Celgene Corp, Summit, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [31] UPADACITINIB PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR EFFICACY AND SAFETY IN PSORIATIC ARTHRITIS ANALYSES OF THE PHASE 3 SELECT-PsA STUDIES
    Muensterman, E.
    Engelhardt, B.
    Gopalakrishnan, S.
    Anderson, J.
    Mohamed, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 805 - 806
  • [32] Exposure-response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis
    Khatri, Amit
    Klunder, Ben
    Peloso, Paul M.
    Othman, Ahmed A.
    RHEUMATOLOGY, 2019, 58 (02) : 352 - 360
  • [33] Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia Rheumatica
    Xu, Christine
    Denney, William S.
    Liu, Ying
    Sloane, Jennifer
    Diab, Remco
    Abdallah, Hisham
    Macha, Sreeraj
    Dasgupta, Bhaskar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [34] Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis
    Hu, Chuanpu
    Xu, Zhenhua
    Zhang, Yi
    Rahman, Mahboob U.
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 639 - 648
  • [35] Exposure-Response Analyses of Upadacitinib Effects on Plasma Biomarkers in Rheumatoid Arthritis Patients
    Qian, Yuli
    Cai, Fang
    Sornasse, Thierry
    Shen, Jie
    Camp, Heidi
    Mohamed, Mohamed-Eslam
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 584 - 585
  • [36] BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Kourlaba, G.
    Batsi, M.
    Vostitsanou, Z.
    Maniadakis, N.
    VALUE IN HEALTH, 2018, 21 : S424 - S424
  • [37] BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS IN GREECE
    Guo, W.
    Han, S.
    Zhang, Y.
    VALUE IN HEALTH, 2018, 21 : S424 - S424
  • [38] Lagging Exposure Information in Cumulative Exposure-Response Analyses
    Richardson, David B.
    Cole, Stephen R.
    Chu, Haitao
    Langholz, Bryan
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 174 (12) : 1416 - 1422
  • [39] Population Pharmacokinetic and Exposure-Response Analyses for Ponatinib in the Phase 3 PhALLCON Study
    Hanley, Michael J.
    Larson, Thomas R.
    Diderichsen, Paul M.
    Largajolli, Anna
    Hui, Katrina
    Srimani, Jaydeep
    Wang, Bingxia
    Vorog, Alexander
    Gupta, Neeraj
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (03):
  • [40] Population pharmacokinetic and exposure-response analyses of guanfacine in Japanese pediatric ADHD patients
    Tsuda, Yoshiyuki
    Matsuo, Yumiko
    Matsumoto, Sayaka
    Wajima, Toshihiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (06) : 365 - 371
12345